Manufactured by
Beyondmedicine Co., Ltd.
Seoul, South Korea
□ Company Overview Beyond Medicine is a digital therapeutics (DTx) startup pioneering software-based treatments for oral and maxillofacial disorders. Founded in 2022 in Seoul, Korea, the company develops Software as a Medical Device (SaMD) solutions that combine behavioral science, data analytics, and digital therapy to improve clinical outcomes. □ Flagship Product – Clickless DTx (FIRST MOVER) Clickless is the world's first digital therapeutic designed for temporomandibular disorder (TMD). It integrates cognitive behavioral therapy (CBT), facial motion tracking, personalized exercises, and mindfulness into a clinically validated six-week 10-minutes per day, non-pharmacological treatment program. Clinical Validation: Results published in Journal of Medical Internet Research (JMIR, 2025) Randomized, sham-controlled multicenter clinical trial (102 patients, 2 hospitals, demonstrating significant efficacy and safety in patient outcomes.
© 2026 Suplivia · Home · Browse Products